v3.26.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2023
Dec. 31, 2025
Dec. 31, 2024
Aug. 12, 2024
DisclosureLineElements [Line Items]        
Proceeds from common stock   $ 4,558,455 $ 100,000  
Investment   7,860,083 5,691,084  
Other investments   7,023,583 5,691,084  
Board Of Directors [Member]        
DisclosureLineElements [Line Items]        
Accrued professional fees   32,500    
AG Bio Life Capital I LP [Member]        
DisclosureLineElements [Line Items]        
Shares issued 600,000      
Proceeds from common stock $ 100,000      
Note receivable       $ 522,667
Investment   $ 522,667 $ 522,667